NEW PRODUCT DEVELOPMENT: payments to doctors
Payments that named NEW PRODUCT DEVELOPMENT as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 799
- Transactions
- 3,353
- Average per transaction
- $334
The per-transaction average — $334 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 799 providers the average total is $1,403, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Stryker | $1,119,293 | 99.8% |
| Maquet Cardiovascular L.L.C. | $1,474 | 0.1% |
| Getinge USA Sales, LLC | $400 | 0.0% |